Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04137276Completed
Randomised, open-label trial of ascorbic acid in sepsis (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Sequential Organ Failure Assessment at 72 hours. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04137276.